BFRI
Biofrontera Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.32
+6.45%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.22
- Revenue estimate
- $8.3M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.05
- EPS estimate
- -$0.10
- Revenue actual
- $12.0M
- Revenue estimate
- $9.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -0.3%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.10 | -$0.05 | Beat 52.38% | $12.0M |
| May 14, 2026 | -$0.18 | -$0.41 | Miss -127.78% | $10.1M |
| Mar 19, 2026 | $0.29 | $0.50 | Beat 72.41% | $17.1M |
| Nov 12, 2025 | -$0.60 | -$0.59 | Beat 1.67% | $7.0M |
| Aug 13, 2025 | -$0.45 | -$0.57 | Miss -26.67% | $9.0M |
| May 15, 2025 | -$0.14 | -$0.47 | Miss -235.71% | $8.6M |
| Mar 21, 2025 | $0.02 | -$2.33 | Miss -11750.00% | $12.6M |
| Aug 14, 2024 | -$1.19 | -$1.12 | Beat 5.88% | $7.8M |
| May 15, 2024 | -$1.63 | -$1.85 | Miss -13.50% | $7.9M |
| Mar 15, 2024 | -$1.19 | -$2.33 | Miss -95.80% | $10.6M |
| Nov 9, 2023 | -$4.23 | -$4.64 | Miss -9.69% | $8.9M |
| Aug 11, 2023 | -$5.14 | -$6.14 | Miss -19.46% | $5.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026